Interpretation and use of FRAX in clinical practice

J. A. Kanis, D. Hans, C. Cooper, S. Baim, J. P. Bilezikian, N. Binkley, J. A. Cauley, J. E. Compston, B. Dawson-Hughes, G. El-Hajj Fuleihan, H. Johansson, W. D. Leslie, E. M. Lewiecki, M. Luckey, A. Oden, S. E. Papapoulos, C. Poiana, R. Rizzoli, D. A. Wahl, E. V. McCloskey

Research output: Contribution to journalArticle

309 Citations (Scopus)

Abstract

Summary: The introduction of the WHO FRAX® algorithms has facilitated the assessment of fracture risk on the basis of fracture probability. Its use in fracture risk prediction has strengths, but also limitations of which the clinician should be aware and are the focus of this review Introduction: The International Osteoporosis Foundation (IOF) and the International Society for Clinical Densitometry (ISCD) appointed a joint Task Force to develop resource documents in order to make recommendations on how to improve FRAX and better inform clinicians who use FRAX. The Task Force met in November 2010 for 3 days to discuss these topics which form the focus of this review. Methods: This study reviews the resource documents and joint position statements of ISCD and IOF. Results: Details on the clinical risk factors currently used in FRAX are provided, and the reasons for the exclusion of others are provided. Recommendations are made for the development of surrogate models where country-specific FRAX models are not available. Conclusions: The wish list of clinicians for the modulation of FRAX is large, but in many instances, these wishes cannot presently be fulfilled; however, an explanation and understanding of the reasons may be helpful in translating the information provided by FRAX into clinical practice.

Original languageEnglish
Pages (from-to)2395-2411
Number of pages17
JournalOsteoporosis International
Volume22
Issue number9
DOIs
StatePublished - Sep 1 2011

Fingerprint

Advisory Committees
Osteoporosis
Joints
Densitometry

Keywords

  • Bone mineral density
  • Clinical risk factors
  • Fracture probability
  • Risk assessment

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

Kanis, J. A., Hans, D., Cooper, C., Baim, S., Bilezikian, J. P., Binkley, N., ... McCloskey, E. V. (2011). Interpretation and use of FRAX in clinical practice. Osteoporosis International, 22(9), 2395-2411. https://doi.org/10.1007/s00198-011-1713-z

Interpretation and use of FRAX in clinical practice. / Kanis, J. A.; Hans, D.; Cooper, C.; Baim, S.; Bilezikian, J. P.; Binkley, N.; Cauley, J. A.; Compston, J. E.; Dawson-Hughes, B.; El-Hajj Fuleihan, G.; Johansson, H.; Leslie, W. D.; Lewiecki, E. M.; Luckey, M.; Oden, A.; Papapoulos, S. E.; Poiana, C.; Rizzoli, R.; Wahl, D. A.; McCloskey, E. V.

In: Osteoporosis International, Vol. 22, No. 9, 01.09.2011, p. 2395-2411.

Research output: Contribution to journalArticle

Kanis, JA, Hans, D, Cooper, C, Baim, S, Bilezikian, JP, Binkley, N, Cauley, JA, Compston, JE, Dawson-Hughes, B, El-Hajj Fuleihan, G, Johansson, H, Leslie, WD, Lewiecki, EM, Luckey, M, Oden, A, Papapoulos, SE, Poiana, C, Rizzoli, R, Wahl, DA & McCloskey, EV 2011, 'Interpretation and use of FRAX in clinical practice', Osteoporosis International, vol. 22, no. 9, pp. 2395-2411. https://doi.org/10.1007/s00198-011-1713-z
Kanis JA, Hans D, Cooper C, Baim S, Bilezikian JP, Binkley N et al. Interpretation and use of FRAX in clinical practice. Osteoporosis International. 2011 Sep 1;22(9):2395-2411. https://doi.org/10.1007/s00198-011-1713-z
Kanis, J. A. ; Hans, D. ; Cooper, C. ; Baim, S. ; Bilezikian, J. P. ; Binkley, N. ; Cauley, J. A. ; Compston, J. E. ; Dawson-Hughes, B. ; El-Hajj Fuleihan, G. ; Johansson, H. ; Leslie, W. D. ; Lewiecki, E. M. ; Luckey, M. ; Oden, A. ; Papapoulos, S. E. ; Poiana, C. ; Rizzoli, R. ; Wahl, D. A. ; McCloskey, E. V. / Interpretation and use of FRAX in clinical practice. In: Osteoporosis International. 2011 ; Vol. 22, No. 9. pp. 2395-2411.
@article{0e63e57296aa40cf92455878405d14d8,
title = "Interpretation and use of FRAX in clinical practice",
abstract = "Summary: The introduction of the WHO FRAX{\circledR} algorithms has facilitated the assessment of fracture risk on the basis of fracture probability. Its use in fracture risk prediction has strengths, but also limitations of which the clinician should be aware and are the focus of this review Introduction: The International Osteoporosis Foundation (IOF) and the International Society for Clinical Densitometry (ISCD) appointed a joint Task Force to develop resource documents in order to make recommendations on how to improve FRAX and better inform clinicians who use FRAX. The Task Force met in November 2010 for 3 days to discuss these topics which form the focus of this review. Methods: This study reviews the resource documents and joint position statements of ISCD and IOF. Results: Details on the clinical risk factors currently used in FRAX are provided, and the reasons for the exclusion of others are provided. Recommendations are made for the development of surrogate models where country-specific FRAX models are not available. Conclusions: The wish list of clinicians for the modulation of FRAX is large, but in many instances, these wishes cannot presently be fulfilled; however, an explanation and understanding of the reasons may be helpful in translating the information provided by FRAX into clinical practice.",
keywords = "Bone mineral density, Clinical risk factors, Fracture probability, Risk assessment",
author = "Kanis, {J. A.} and D. Hans and C. Cooper and S. Baim and Bilezikian, {J. P.} and N. Binkley and Cauley, {J. A.} and Compston, {J. E.} and B. Dawson-Hughes and {El-Hajj Fuleihan}, G. and H. Johansson and Leslie, {W. D.} and Lewiecki, {E. M.} and M. Luckey and A. Oden and Papapoulos, {S. E.} and C. Poiana and R. Rizzoli and Wahl, {D. A.} and McCloskey, {E. V.}",
year = "2011",
month = "9",
day = "1",
doi = "10.1007/s00198-011-1713-z",
language = "English",
volume = "22",
pages = "2395--2411",
journal = "Osteoporosis International",
issn = "0937-941X",
publisher = "Springer London",
number = "9",

}

TY - JOUR

T1 - Interpretation and use of FRAX in clinical practice

AU - Kanis, J. A.

AU - Hans, D.

AU - Cooper, C.

AU - Baim, S.

AU - Bilezikian, J. P.

AU - Binkley, N.

AU - Cauley, J. A.

AU - Compston, J. E.

AU - Dawson-Hughes, B.

AU - El-Hajj Fuleihan, G.

AU - Johansson, H.

AU - Leslie, W. D.

AU - Lewiecki, E. M.

AU - Luckey, M.

AU - Oden, A.

AU - Papapoulos, S. E.

AU - Poiana, C.

AU - Rizzoli, R.

AU - Wahl, D. A.

AU - McCloskey, E. V.

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Summary: The introduction of the WHO FRAX® algorithms has facilitated the assessment of fracture risk on the basis of fracture probability. Its use in fracture risk prediction has strengths, but also limitations of which the clinician should be aware and are the focus of this review Introduction: The International Osteoporosis Foundation (IOF) and the International Society for Clinical Densitometry (ISCD) appointed a joint Task Force to develop resource documents in order to make recommendations on how to improve FRAX and better inform clinicians who use FRAX. The Task Force met in November 2010 for 3 days to discuss these topics which form the focus of this review. Methods: This study reviews the resource documents and joint position statements of ISCD and IOF. Results: Details on the clinical risk factors currently used in FRAX are provided, and the reasons for the exclusion of others are provided. Recommendations are made for the development of surrogate models where country-specific FRAX models are not available. Conclusions: The wish list of clinicians for the modulation of FRAX is large, but in many instances, these wishes cannot presently be fulfilled; however, an explanation and understanding of the reasons may be helpful in translating the information provided by FRAX into clinical practice.

AB - Summary: The introduction of the WHO FRAX® algorithms has facilitated the assessment of fracture risk on the basis of fracture probability. Its use in fracture risk prediction has strengths, but also limitations of which the clinician should be aware and are the focus of this review Introduction: The International Osteoporosis Foundation (IOF) and the International Society for Clinical Densitometry (ISCD) appointed a joint Task Force to develop resource documents in order to make recommendations on how to improve FRAX and better inform clinicians who use FRAX. The Task Force met in November 2010 for 3 days to discuss these topics which form the focus of this review. Methods: This study reviews the resource documents and joint position statements of ISCD and IOF. Results: Details on the clinical risk factors currently used in FRAX are provided, and the reasons for the exclusion of others are provided. Recommendations are made for the development of surrogate models where country-specific FRAX models are not available. Conclusions: The wish list of clinicians for the modulation of FRAX is large, but in many instances, these wishes cannot presently be fulfilled; however, an explanation and understanding of the reasons may be helpful in translating the information provided by FRAX into clinical practice.

KW - Bone mineral density

KW - Clinical risk factors

KW - Fracture probability

KW - Risk assessment

UR - http://www.scopus.com/inward/record.url?scp=80052313108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052313108&partnerID=8YFLogxK

U2 - 10.1007/s00198-011-1713-z

DO - 10.1007/s00198-011-1713-z

M3 - Article

C2 - 21779818

AN - SCOPUS:80052313108

VL - 22

SP - 2395

EP - 2411

JO - Osteoporosis International

JF - Osteoporosis International

SN - 0937-941X

IS - 9

ER -